Syneos Health, Inc. Stock
Equities
SYNH
US87166B1026
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 23-06-30 |
Michael Brooks
COO | Chief Operating Officer | 50 | 21-07-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 23-09-27 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
James Dimitri
BRD | Director/Board Member | - | 23-09-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 8 M€ | -.--% | ||
0.77% | 2 M€ | +5.19% | ||
0.50% | 0 M€ | 0.00% | - | |
0.36% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.11% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |